Key Insights

Highlights

Treatment Research

3 treatments under study, led by Evaluation Of Pituitary Endocrine Function

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Common Treatments

  • Evaluation Of Pituitary Endocrine Function1
  • Evaluation Of Clinical Outcome1
  • Evaluation Of Neuropsychological Function1

Active Sponsors

  • Dr. Rita Bertuetti1
  • Cambridge University Hospitals NHS Foundation Trust1

Top Investigators

Related Conditions

  • Thyroid Disfunction1
  • Subarachnoid Haemorrhage From Cerebral Aneurism Rupture1

Activity Timeline